Randall N. Hyer
Chief Executive Officer Merlin Biotech
Seminars
Tuesday 22nd July 2025
Tumor Suppression With mRNA-Encoded Ubiquitin-Specific Protease 6 (USP6) in Broad Pediatric & Adult Cancer Indications
12:30 pm
Wednesday 23rd July 2025
Panel Discussion: Examining the Pathway of mRNA Cancer Vaccines From Preclinical to Clinical Development to Get Effective Therapies to Cancer Patients Faster
1:35 pm
